Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP was delisted on the 5th of October, 2023.
141 hedge funds and large institutions have $973M invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2014 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 50 increasing their positions, 41 reducing their positions, and 19 closing their positions.
504% more call options, than puts
Call options by funds: $27.9M | Put options by funds: $4.61M
121% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 19
22% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 41
19% more funds holding
Funds holding: 118 → 141 (+23)
12% more capital invested
Capital invested by funds: $869M → $973M (+$104M)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$38.5M |
| 2 |
BLM
Bennett Lawrence Management
New York
|
+$12M |
| 3 |
O
OppenheimerFunds
New York
|
+$8.41M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.38M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$8.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$16.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$13M |
| 3 |
DM
Deerfield Management
New York
|
-$9.96M |
| 4 |
Millennium Management
New York
|
-$7.94M |
| 5 |
D.E. Shaw & Co
New York
|
-$7.83M |
HZNP Hedge Fund Activity: Q2 2014 in Review
141 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q2 2014, worth a combined $973M — up 12% from $869M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new HZNP positions and 19 closed out — a net gain of 23 holders — while 50 added to existing stakes and 41 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $38.5M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $16.1M sold.
- 141 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q2 2014, up from 118 in Q1 2014.
- Funds reported $973M of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q2 2014, up 12% quarter-over-quarter.
- 42 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q2 2014 and 19 closed out, a net change of +23 holders.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q2 2014 was HealthCor Management, an estimated $38.5M added.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q2 2014 was Oxford Asset Management, an estimated $16.1M sold.
Based on aggregated 13F filings for Q2 2014.